A Novel Approach for Glycero-(9,10-trioxolane)-Trialeate Incorporation into Poly(lactic acid)/Poly(ɛ-caprolactone) Blends for Biomedicine and Packaging.
Olga V Alexeeva, Anatoliy A Olkhov, Marina L Konstantinova, Vyacheslav V Podmasterev, Tuyara V Petrova, Levon Yu Martirosyan, Olga K Karyagina, Sergey S Kozlov, Sergey M Lomakin, Ilya V Tretyakov and 2 more
Article in Polymers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
3 citing papers in PubMed, 6 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
12 authors at 4 institutions in 2 countries.
Olga V AlexeevaEmanuel Institute of Biochemical Physics of Russian Academy of Sciences, 119334 Moscow, Russia.ORCID 0000-0001-8982-3959
Anatoliy A OlkhovEmanuel Institute of Biochemical Physics of Russian Academy of Sciences, 119334 Moscow, Russia.ORCID 0000-0003-0615-6914
Marina L KonstantinovaEmanuel Institute of Biochemical Physics of Russian Academy of Sciences, 119334 Moscow, Russia.
Vyacheslav V PodmasterevEmanuel Institute of Biochemical Physics of Russian Academy of Sciences, 119334 Moscow, Russia.
Tuyara V PetrovaN.N. Semenov Federal Research Center for Chemical Physics Russian Academy of Sciences, 119991 Moscow, Russia.
Levon Yu MartirosyanEmanuel Institute of Biochemical Physics of Russian Academy of Sciences, 119334 Moscow, Russia.
Olga K KaryaginaEmanuel Institute of Biochemical Physics of Russian Academy of Sciences, 119334 Moscow, Russia.
Sergey S KozlovEmanuel Institute of Biochemical Physics of Russian Academy of Sciences, 119334 Moscow, Russia.
Sergey M LomakinEmanuel Institute of Biochemical Physics of Russian Academy of Sciences, 119334 Moscow, Russia.ORCID 0000-0003-3191-8415
Ilya V TretyakovN.N. Semenov Federal Research Center for Chemical Physics Russian Academy of Sciences, 119991 Moscow, Russia.
Valentina SiracusaDepartment of Chemical Science (DSC), University of Catania, Viale A. Doria 6, 95125 Catania, Italy.ORCID 0000-0001-9055-5082
Alexey L IordanskiiN.N. Semenov Federal Research Center for Chemical Physics Russian Academy of Sciences, 119991 Moscow, Russia.ORCID 0000-0003-0771-0825
Institute of Biochemical Physics NM Emanuel · RUSemenov Institute of Chemical Physics · RUPlekhanov Russian University of Economics · RUUniversity of Catania · IT
Funding
Ministry of Science and Higher Education of the Russian Federation 12041300207-2
6 · The paper itself
Abstract
The product of ozonolysis, glycero-(9,10-trioxolane)-trioleate (ozonide of oleic acid triglyceride, [OTOA]), was incorporated into polylactic acid/polycaprolactone (PLA/PCL) blend films in the amount of 1, 5, 10, 20, 30 and 40%
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
A Novel Approach for Glycero-(9,10-trioxolane)-Trialeate Incorporation into Poly(lactic acid)/Poly(ɛ-caprolactone) Blends for Biomedicine and Packaging. · full record | OpenQuestion